244 related articles for article (PubMed ID: 29848909)
41. Accuracy of Sensititre YeastOne echinocandins epidemiological cut-off values for identification of FKS mutant Candida albicans and Candida glabrata: a ten year national survey of the Fungal Infection Network of Switzerland (FUNGINOS).
Kritikos A; Neofytos D; Khanna N; Schreiber PW; Boggian K; Bille J; Schrenzel J; Mühlethaler K; Zbinden R; Bruderer T; Goldenberger D; Pfyffer G; Conen A; Van Delden C; Zimmerli S; Sanglard D; Bachmann D; Marchetti O; Lamoth F;
Clin Microbiol Infect; 2018 Nov; 24(11):1214.e1-1214.e4. PubMed ID: 29909005
[TBL] [Abstract][Full Text] [Related]
42. Resistance in human pathogenic yeasts and filamentous fungi: prevalence, underlying molecular mechanisms and link to the use of antifungals in humans and the environment.
Jensen RH
Dan Med J; 2016 Oct; 63(10):. PubMed ID: 27697142
[TBL] [Abstract][Full Text] [Related]
43. Emergence of echinocandin-resistant Candida spp. in a hospital setting: a consequence of 10 years of increasing use of antifungal therapy?
Fekkar A; Dannaoui E; Meyer I; Imbert S; Brossas JY; Uzunov M; Mellon G; Nguyen S; Guiller E; Caumes E; Leblond V; Mazier D; Fievet MH; Datry A
Eur J Clin Microbiol Infect Dis; 2014 Sep; 33(9):1489-96. PubMed ID: 24715154
[TBL] [Abstract][Full Text] [Related]
44. Update on antifungal resistance in Aspergillus and Candida.
Arendrup MC
Clin Microbiol Infect; 2014 Jun; 20 Suppl 6():42-8. PubMed ID: 24372701
[TBL] [Abstract][Full Text] [Related]
45. Fungal echinocandin resistance.
Walker LA; Gow NA; Munro CA
Fungal Genet Biol; 2010 Feb; 47(2):117-26. PubMed ID: 19770064
[TBL] [Abstract][Full Text] [Related]
46. Activity of a long-acting echinocandin, CD101, determined using CLSI and EUCAST reference methods, against Candida and Aspergillus spp., including echinocandin- and azole-resistant isolates.
Pfaller MA; Messer SA; Rhomberg PR; Jones RN; Castanheira M
J Antimicrob Chemother; 2016 Oct; 71(10):2868-73. PubMed ID: 27287236
[TBL] [Abstract][Full Text] [Related]
47. Update on echinocandin antifungals.
Kauffman CA; Carver PL
Semin Respir Crit Care Med; 2008 Apr; 29(2):211-9. PubMed ID: 18366002
[TBL] [Abstract][Full Text] [Related]
48. Structural and mechanistic insights into fungal β-1,3-glucan synthase FKS1.
Hu X; Yang P; Chai C; Liu J; Sun H; Wu Y; Zhang M; Zhang M; Liu X; Yu H
Nature; 2023 Apr; 616(7955):190-198. PubMed ID: 36949198
[TBL] [Abstract][Full Text] [Related]
49. Breakpoints for antifungal agents: an update from EUCAST focussing on echinocandins against Candida spp. and triazoles against Aspergillus spp.
Arendrup MC; Cuenca-Estrella M; Lass-Flörl C; Hope WW
Drug Resist Updat; 2013 Dec; 16(6):81-95. PubMed ID: 24618110
[TBL] [Abstract][Full Text] [Related]
50. Micafungin: a new echinocandin.
Chandrasekar PH; Sobel JD
Clin Infect Dis; 2006 Apr; 42(8):1171-8. PubMed ID: 16575738
[TBL] [Abstract][Full Text] [Related]
51. Candida and candidaemia. Susceptibility and epidemiology.
Arendrup MC
Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
[TBL] [Abstract][Full Text] [Related]
52. Caspofungin for the treatment of pediatric fungal infections.
Fisher BT; Zaoutis T
Pediatr Infect Dis J; 2008 Dec; 27(12):1099-102. PubMed ID: 19057369
[No Abstract] [Full Text] [Related]
53. First Case of Echinocandin-Resistant Candida albicans in Korea.
Park MS; Park JE; Song DJ; Huh HJ; Park S; Kang CI; Shin JH; Lee NY
Ann Lab Med; 2017 Nov; 37(6):556-558. PubMed ID: 28841000
[No Abstract] [Full Text] [Related]
54. Benzylic Dehydroxylation of Echinocandin Antifungal Drugs Restores Efficacy against Resistance Conferred by Mutated Glucan Synthase.
Logviniuk D; Jaber QZ; Dobrovetsky R; Kozer N; Ksiezopolska E; Gabaldón T; Carmeli S; Fridman M
J Am Chem Soc; 2022 Apr; 144(13):5965-5975. PubMed ID: 35347986
[TBL] [Abstract][Full Text] [Related]
55. Echinocandins: production and applications.
Emri T; Majoros L; Tóth V; Pócsi I
Appl Microbiol Biotechnol; 2013 Apr; 97(8):3267-84. PubMed ID: 23463246
[TBL] [Abstract][Full Text] [Related]
56. In vitro activity of echinocandins against non-Candida albicans: is echinocandin antifungal activity the same?
Espinel-Ingroff A; Cantón E
Enferm Infecc Microbiol Clin; 2011 Mar; 29 Suppl 2():3-9. PubMed ID: 21420570
[TBL] [Abstract][Full Text] [Related]
57. FKS mutant Candida glabrata: risk factors and outcomes in patients with candidemia.
Beyda ND; John J; Kilic A; Alam MJ; Lasco TM; Garey KW
Clin Infect Dis; 2014 Sep; 59(6):819-25. PubMed ID: 24879785
[TBL] [Abstract][Full Text] [Related]
58. The Paradoxical Effect of Echinocandins in Aspergillus fumigatus Relies on Recovery of the β-1,3-Glucan Synthase Fks1.
Loiko V; Wagener J
Antimicrob Agents Chemother; 2017 Feb; 61(2):. PubMed ID: 27872079
[TBL] [Abstract][Full Text] [Related]
59. Presence of L701 M mutation in the FKS1 gene of echinocandin-susceptible Candida krusei isolates.
Lallitto F; Prigitano A; Mangione F; Piralla A; Tamarozzi F; Marone P; Cavanna C
Diagn Microbiol Infect Dis; 2018 Dec; 92(4):311-314. PubMed ID: 30131237
[TBL] [Abstract][Full Text] [Related]
60. Multicenter Study of Method-Dependent Epidemiological Cutoff Values for Detection of Resistance in Candida spp. and Aspergillus spp. to Amphotericin B and Echinocandins for the Etest Agar Diffusion Method.
Espinel-Ingroff A; Arendrup M; Cantón E; Cordoba S; Dannaoui E; García-Rodríguez J; Gonzalez GM; Govender NP; Martin-Mazuelos E; Lackner M; Lass-Flörl C; Linares Sicilia MJ; Rodriguez-Iglesias MA; Pelaez T; Shields RK; Garcia-Effron G; Guinea J; Sanguinetti M; Turnidge J
Antimicrob Agents Chemother; 2017 Jan; 61(1):. PubMed ID: 27799206
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
